nach oben

Erschienen in:

20.06.2015

Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity

verfasst von: Sevim Bavbek, Seçil Kepil Özdemir, Beyza Doğanay Erdoğan, Işıl Karaboğa, Suna Büyüköztürk, Aslı Gelincik, İnsu Yılmaz, Özlem Göksel, Adile Berna Dursun, Gül Karakaya, Ali Fuat Kalyoncu, Ferhan Özşeker, Gülden Paşaoğlu Karakış, Ferda Öner Erkekol, Gözde Köycü, Metin Keren, Ilaria Baiardini, Antonino Romano

Erschienen in: Quality of Life Research | Ausgabe 1/2016

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

The first disease-specific quality-of-life questionnaire in patients with drug hypersensitivity, Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q), was developed and validated recently. The aim of this study was to assess validity, reliability and responsiveness to interventions of the Turkish version of the DrHy-Q.

Methods

The Turkish version of the DrHy-Q was administered to prospectively enrolled 736 patients with drug hypersensitivity from ten allergy units. To assess validity, all patients completed the validated Turkish version of Psychological General Well-Being Index (PGWBI). For test–retest reliability, 182 patients completed the DrHy-Q 1 week after the first questionnaire administration without any intervention. Responsiveness was assessed on 97 patients who had a DrHy-Q recorded at a follow-up visit after the intervention.

Results

The internal consistency and test–retest reliability of the scale were adequate (Cronbach’s alpha = 0.934, intra-class correlation coefficient = 0.783). The DrHy-Q scores showed weak negative correlations with the PGWBI total and domain scores (r = − 0.378 to −0.254, p < 0.001). DrHy-Q was able to discriminate the patients with one drug hypersensitivity reaction from the patients with two and above two reactions (p = 0.012 and p < 0.001, respectively), and the patients who experienced a respiratory reaction from the patients who did not (p = 0.018). However, it did not discriminate the patients with comorbid disease including psychiatric comorbidity (p > 0.05). The baseline DrHy-Q scores were significantly higher than the post-intervention scores (p = 0.008).

Conclusion

The Turkish version of DrHy-Q is reliable and valid for evaluating quality of life in patients with drug hypersensitivity, and it appeared responsive to interventions.

Vorheriger Artikel Cultural adaptation and validation of the Chinese version of the Fatigue Severity Scale in patients with major depressive disorder and nondepressive people

Nächster Artikel Normative data and psychometric properties of the Connor–Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong Kong

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Baiardini, I., Pasquali, M., Giardini, A., Specchia, C., Passalacqua, G., Venturi, S., et al. (2003). Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy, 38, 289–294.CrossRef

Gomes, E., Cardoso, M. F., Praça, F., Gomes, L., Mariño, E., & Demoly, P. (2004). Self-reported drug allergy in a general Portuguese population. Clinical and Experimental Allergy, 34, 1597–1601.PubMedCrossRef

Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., et al. (2014). International consensus on drug allergy. Allergy, 69, 420–437.PubMedCrossRef

Bavbek, S., Erkekol, F. Ö., Celik, G. E., Gönüllü, I., & Misirligil, Z. (2011). Self-reported prevalence of hypersensitivity reactions against drugs among medical students: Does awareness cause any difference? Pharmacoepidemiology and Drug Safety, 20(2), 154–161.PubMedCrossRef

Bavbek, S., Celik, E. G., Aydın, O., Oner Erkekol, F., Kursun, N., Mungan, D., et al. (2012). Prevalence of hypersensitivity reactions against drugs among adult population in Turkey: A self reported survey. Journal of Public Health, 20, 585–592.CrossRef

Bavbek, S., Pasaoğlu, G., Canat, S., Sağduyu, G., & Mısırlığıl, Z. (2006). Allergy to drugs: How important for psychological epidemiology? International Journal on Psychiatry in Clinical Practice, 10(1), 64–68.CrossRef

Baiardini, I., Braido, F., Fassio, O., Calia, R., Canonica, G. W., Romano, A., & DrHy-Q PROs Research Italian Group. (2011). Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Annals of Allergy, Asthma & Immunology, 106, 330–335.CrossRef

Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. New England Journal of Medicine, 334, 835–840.PubMedCrossRef

Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef

10.

Streiner, D. L., & Norman, G. R. (1995). Health measurement scales. A practical guide to their development and use (2nd ed., pp. 104–126). New York: Oxford Medical Publications.

11.

Fleiss, J. L., Levin, B., & Paik, M. C. (2003). Statistical methods for rates and proportions. Hoboken, NJ: Wiley.CrossRef

12.

Ay, S., Koldaş Doğan, Ş., Evcik, D., Gök, H., Tur, B. S., & Gökmen, D. (2010). Reliability and validity of psychological general well-being index in Turkish population. Turkish Journal of Physical Medicine and Rehabilitation, 56, 161–169.

13.

Dupuy, H. (1984). The psychological general well-being (PGWB) index. In N. K. Wenger, M. E. Mattson, C. D. Furberg, & J. Elinson (Eds.), Assessment of quality of life in clinical trials of cardiovascular therapies (pp. 170–183). Greenwich, CT: Le Jacq Publishing Inc.

14.

Ertam, I., Kitapcioglu, G., Aksu, K., et al. (2009). Quality of life and its relation with disease severity in Behçet’s disease. Clinical and Experimental Rheumatology, 27, S18–S22.PubMed

15.

Pallant, J. F., Kenan, A. M., Misajon, R., Conaghan, P. G., & Tennant, A. (2009). Measuring the impact and distress of osteoarthritis from the patients’ perspective. Health and Quality of Life Outcomes, 29(7), 37.CrossRef

16.

Pai, A. L., Mullins, L. L., Drotar, D., Burant, C., Wagner, J., & Chaney, J. M. (2007). Exploratory and confirmatory factor analysis of the child uncertainty in illness scale among children with chronic illness. Journal of Pediatric Psychology, 32, 288–296.PubMedCrossRef

17.

Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W, Jr, & Schuler, T. C. (2007). Understanding the minimum clinically important difference: A review of concepts and methods. The Spine Journal, 7, 541–546.PubMedCrossRef

18.

Cohen, J. (1977). Statistical power: Analysis for behavioral sciences. New York: Academic Press.

19.

Muthen, L. K., & Muthen, B. O. (1998–2007). Mplus user’s guide, 5th edn. Los Angeles, CA: Muthen and Muthen.

20.

US Food and Drug Administration (FDA). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/Guidelines/UCM193282.pdf

21.

Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., et al. (2010). Global allergy and asthma European network. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA(2)LEN task force position paper. Allergy, 65(3), 290–295.PubMedCrossRef

22.

Smith, K. W., Avis, N. E., & Assmann, S. F. (1999). Distinguishing between quality of life and health status in quality of life research: A metaanalysis. Quality of Life Research, 8, 447–459.PubMedCrossRef

23.

Simons, F. E., Ardusso, L. R., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., et al. (2011). World Allergy Organization anaphylaxis guidelines: Summary. Journal of Allergy and Clinical Immunology, 127, 587–593.PubMedCrossRef

Titel: Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity
verfasst von: Sevim Bavbek
Seçil Kepil Özdemir
Beyza Doğanay Erdoğan
Işıl Karaboğa
Suna Büyüköztürk
Aslı Gelincik
İnsu Yılmaz
Özlem Göksel
Adile Berna Dursun
Gül Karakaya
Ali Fuat Kalyoncu
Ferhan Özşeker
Gülden Paşaoğlu Karakış
Ferda Öner Erkekol
Gözde Köycü
Metin Keren
Ilaria Baiardini
Antonino Romano
Publikationsdatum: 20.06.2015
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 1/2016
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-015-1051-2

Springer Professional

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 1/2016

Anemia has a negative impact on self-rated health in kidney transplant recipients with well-functioning grafts: findings from an 8-year follow-up study

How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?

Quality of life in rehabilitation outpatients: normal values and a comparison with the general Dutch population and psychiatric patients

Normative data and psychometric properties of the Connor–Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong Kong

Assessing the burden of childhood asthma: validation of electronic versions of the Mini Pediatric and Pediatric Asthma Caregiver’s Quality of Life Questionnaires

Impact of untreated dental caries and its clinical consequences on the oral health-related quality of life of schoolchildren aged 8–10 years

Premium Partner